More than 800 million individuals have contracted SARSCOV2 infection worldwide. It was estimated that almost 10-20% of these might suffer from Long COVID. It is a multisystemic syndrome, which negatively affects the quality of life with a significant burden of health loss compared to COVID negative individuals. Moreover, the risk of sequelae still remains high at 2 years in both non-hospitalized and hospitalized individuals. This review summarizes studies regarding long COVID and clarifies the definitions, the risk factors and the management of this syndrome. Finally, it delves into the most frequent long-term outcomes, especially postural orthostatic tachycardia syndrome” (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), brain fog, and their therapeutical possibilities.

Cogliandro, V., Bonfanti, P. (2024). Long COVID: lights and shadows on the clinical characterization of this emerging pathology. NEW MICROBIOLOGICA, 47(1), 15-27.

Long COVID: lights and shadows on the clinical characterization of this emerging pathology

Bonfanti, P
2024

Abstract

More than 800 million individuals have contracted SARSCOV2 infection worldwide. It was estimated that almost 10-20% of these might suffer from Long COVID. It is a multisystemic syndrome, which negatively affects the quality of life with a significant burden of health loss compared to COVID negative individuals. Moreover, the risk of sequelae still remains high at 2 years in both non-hospitalized and hospitalized individuals. This review summarizes studies regarding long COVID and clarifies the definitions, the risk factors and the management of this syndrome. Finally, it delves into the most frequent long-term outcomes, especially postural orthostatic tachycardia syndrome” (POTS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), brain fog, and their therapeutical possibilities.
Articolo in rivista - Review Essay
Long COVID; long term outcomes; post COVID syndrome; post-acute COVID sequalae; risk factors;
English
2024
47
1
15
27
reserved
Cogliandro, V., Bonfanti, P. (2024). Long COVID: lights and shadows on the clinical characterization of this emerging pathology. NEW MICROBIOLOGICA, 47(1), 15-27.
File in questo prodotto:
File Dimensione Formato  
Cogliandro-2024-New Miciobiol-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 313.44 kB
Formato Adobe PDF
313.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/475341
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact